Overcoming drug resistance in ALK-rearranged lung cancer

N Engl J Med. 2014 Mar 27;370(13):1250-1. doi: 10.1056/NEJMe1316173.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anaplastic Lymphoma Kinase
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Receptor Protein-Tyrosine Kinases / genetics*
  • Sulfones / administration & dosage*

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Sulfones
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases
  • ceritinib